The aim of this commentary is to discuss from a rehabilitation perspective the Cochrane Review "Exercise therapy for chronic low back pain" (1) by Hayden JA, Ellis J, Ogilvie R, Malmivaara A and van ...Tulder MW 1 published by Cochrane Musculoskeletal Group. This Cochrane Corner is produced in agreement with Journal of Rehabilitation Medicine by Cochrane Rehabilitation with views* of the review summary authors in the "implications for practice" section.
This summary is based on a Cochrane Review previously published in the Cochrane Database of Systematic Reviews 2021, Issue 9, Art. No.:CD009790, DOI: 10.1002/14651858.CD009790.pub2 (see www.cochranelibrary.com for information). Cochrane Reviews are regularly updated as new evidence emerges and in response to feedback, and Cochrane Database of Systematic Reviews should be consulted for the most recent version of the review.
* The views expressed in the summary with commentary are those of the Cochrane Corner author (different than the original Cochrane Review authors) and do not represent the Cochrane Library or Journal of Rehabilitation Medicine.
Osteoporotski prijelomi predstavljaju velik teret kako za bolesnika tako i za zdravstveni sustav, uključujući visoke direktne i indirektne troškove. Starenjem stanovništva njihova se pojavnost ...povisuje. Prepoznavanje potrebe za liječenjem osteoporoze i posljedičnih prijeloma je nedostatno, a učinkovitost slaba uslijed relativno visokog stupnja nesuradljivosti (perzistencije i adherencije) na terapiju. Prethodni prijelom jedan je od najznačajnijih čimbenika rizika za sljedeći prijelom. Stoga se pojavila potreba za sustavnim strategijama sekundarne prevencije,
koje su razvijene i provode se u brojnim zemljama kroz programe naziva Servis povezan s prijelomom (engl. Fracture Liaison Service, skr. FLS). FLS uključuje zdravstvene stručnjake različitih profila, a ključnu ulogu ima koordinator. Identifikacija bolesnika s niskoenergetskim prijelomom polazišna je točka procesa FLS-a, a sam proces funkcionira na temelju utvrđenog postupnika. Tijekom hospitalizacije provodi se ciljana dijagnostička obrada, procjena rizika za sljedeće prijelome, edukacija bolesnika i njegovih bližnjih/skrbnika, a daju se preporuke za
temeljnu i specifičnu farmakološku antiosteoporotsku terapiju te za druge mjere i postupke (npr. fizikalna terapija, vježbe), uključujući modifikaciju čimbenika rizika i prevenciju padova. Svi nalazi te napose preporuke moraju biti jasno navedene u otpusnom pismu i komunicirane svim članovima tima, kao i liječniku obiteljske medicine. Važno je redovito praćenje tih bolesnika, uz naglasak na suradljivosti kao preduvjetu za uspjeh liječenja i sprječavanje novih prijeloma. Na temelju programa FLS koji je ustanovljen u Kliničkom bolničkom centru Sestre milosrdnice u
Zagrebu, grupa eksperata je konsenzusom predložila ključne elemente, ulogu pojedinih članova multidisciplinarnog tima i postupnik FLS-a HDFRM, s izborom prijeloma u području kuka kao indeksnog prijeloma. Prijedlog je dobio potvrdu na sastanku stručnog društva. Pritom se pridržavalo osnovnih načela FLS-a, identifikacije pacijenata s prijelomom, odgovarajuće evaluacije i individualizirane procjene rizika za sljedeći prijelom, promptnosti početka liječenja i praćenja bolesnika s osiguranjem kontinuiteta terapije. Ovaj dokument o stajalištu (engl. position paper) temeljni je dokument za FLS u hrvatskoj fizijatrijskoj zajednici te vjerujemo da će pridonijeti smanjenju morbiditeta, mortaliteta i sveukupnih zdravstvenih izdataka povezanih s osteoporotskim prijelomima.
Nonpharmacological interventions are one of the mainstreams of treatment for patients with spondyloarthritis (SpA). They include education, measures regarding joint protection, posture and rest, ...therapeutic exercise, physical therapy modalities, orthoses, and acupuncture. A key component in the rehabilitation of patients with SpA entities is therapeutic exercise, which can be performed as land-based or water-based. Positive effects of the exercises are manifested in reducing pain, maintaining mobility, improving posture, increasing aerobic capacity and improving quality of life. The best effects can be obtained when exercise is performed under the supervision of a physiotherapist at a health institution. The majority of studies on therapeutic exercise in SpA are related to ankylosing spondylitis (AS), while there is a paucity of studies devoted to other conditions. Although progress has been made in the quantity and quality of research on this topic, there are still issues regarding the quality of studies and considerable variability among them, which makes it difficult to compare different methods and harmonize and develop rehabilitation protocols according to evidence-based medicine.
The aim of the study was to determine the serum vitamin D levels in patients with psoriatic arthritis (PsA) and compare it with patients with rheumatoid arthritis (RA) and with osteoarthritis (OA), ...as well as to explore the relationship of the vitamin D level with indices of disease activity and functional ability in a real-life setting in a South-European country.
In a cross-sectional study, 120 adult patients with established diagnosis of PsA, RA and OA were consecutively enrolled. Serum 25-hydroxyvitamin D and intact parathyroid hormone were determined. Parameters of disease activity and functional ability were obtained using standard instruments.
Serum vitamin D insufficiency (≤ 75 nmol/L) was found in 74% of patients with PsA, 94% patients with RA and 97% of patients with OA, whereas vitamin D deficiency (≤ 25 nmol/L) was found in 13% of patients with PsA, 39% of patients with RA and in 38% of patients with OA. Compared with RA, patients with PsA had significantly higher serum vitamin D (P = 0.002), and when controlling for age and gender, their serum vitamin D level was significantly associated with disease activity and functional activity.
In the group of rheumatic patients, a high prevalence of serum vitamin D insufficiency/deficiency was found regardless of the type of arthritis. Patients with PsA might have higher levels of vitamin D than patients with RA, and this was associated with disease activity and functional ability. The results of this study indicate that prophylactic supplementation with vitamin D might be recommended for all rheumatic patients.
The reporting of clinical studies in rehabilitation has been criticized in several aspects, including the reporting of patient characteristics. This article aims to contribute to the improvement of ...the reporting of patient characteristics in rehabilitation trials. Specifically, we want to determine the type of information that should be reported in rehabilitation trials that is specific to rehabilitation patients and how this information is captured by current reporting standards.
In the first step, we made a conceptual analysis of characteristics of rehabilitation patients by addressing the specifics of the field of medical rehabilitation, including the definition of rehabilitation and a description of its beneficiaries. In the second step, we compared this reference framework to the current reporting standards, especially the Consolidated Standards of Reporting Trials (CONSORT) statement and its extensions, as well as standards for the reporting of clinical guidelines (agree, right).
Patients included in rehabilitation interventions should be distinguished by specific information. From a clinical perspective, patients dealt with in rehabilitation comprise broader diagnostic groups compared with other clinical settings. Information on comorbidities should be added in the description of the patients. In addition, a description of baseline characteristics of patients should always include functioning characteristics of the patients, including information on relevant context factors, ie, environmental and personal factors. The CONSORT statement aims to provide patient characteristic to enable transferability of results to users. It is represented in terms of selection (inclusion/exclusion) criteria and the description of the resulting samples. Extensions of the CONSORT statement specified that information on socioeconomic variables should be added, and the selection of patient characteristics to be reported at baseline should be based on the selection of outcome variables. In addition, all relevant prognostic variables should be reported. Only one CONSORT extension asks explicitly to include comorbid conditions. The reporting standards on guidelines demand a more comprehensive characterization of patients, specific to the rehabilitation area.
Present reporting standards can only partly address relevant issues pertinent to medical rehabilitation. The present analysis provides a conceptual and empirical framework for the development of reporting standards on patient characteristics in rehabilitation trials.